ВІРДАК

Product Overview

About ВІРДАК

ВІРДАК is a prescription medication containing the active ingredient Daclatasvir, a direct-acting antiviral agent used in the treatment of chronic hepatitis C virus (HCV) infection. It is designed to work in conjunction with other medications to help achieve sustained virologic response (SVR) in patients with genotype 1 or 3 HCV infection.

Key Benefits & Uses

• Treatment of chronic hepatitis C virus (HCV) infection in patients with genotype 1 or 3 HCV infection.
• Used in combination with other medications to help achieve sustained virologic response (SVR).
• May be used in patients with compensated liver cirrhosis or without cirrhosis.

Active Ingredient & Action

Daclatasvir, the active ingredient in ВІРДАК, works by inhibiting the NS5A protein of the hepatitis C virus, which is essential for viral replication. By blocking this protein, Daclatasvir helps to reduce the amount of virus in the body, allowing the immune system to fight the infection more effectively.

Important Notes

ВІРДАК is a prescription medication and should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and treatment regimen to ensure optimal efficacy and minimize the risk of side effects. Patients with pre-existing medical conditions, taking other medications, or pregnant/breastfeeding should consult their doctor before starting treatment with ВІРДАК.